Assay Detail
Binding
CHEMBL4400322
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) cytoplasmic domain expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay
8
Total Activities
8
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
An exploration of solvent-front region high affinity moiety leading to novel potent ALK & ROS1 dual inhibitors with mutant-combating effects.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 8 | 6.21 | 6.21 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL4462528 | — | — | 1 | 6.21 |
| CHEMBL4471142 | — | — | 1 | - |
| CHEMBL4536955 | — | — | 1 | - |
| CHEMBL2403108 | CERITINIB | 4.0 | 1 | - |
| CHEMBL4546844 | — | — | 1 | - |
| CHEMBL4448400 | — | — | 1 | - |
| CHEMBL4562805 | — | — | 1 | - |
| CHEMBL4468370 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL4462528 | — | IC50 | = | 617.0 | nM | 6.21 |
| CHEMBL4471142 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL4536955 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL2403108 | CERITINIB | IC50 | > | 1000.0 | nM | - |
| CHEMBL4546844 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL4448400 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL4562805 | — | IC50 | > | 1000.0 | nM | - |
| CHEMBL4468370 | — | IC50 | > | 1000.0 | nM | - |